Reinsurance Group of America, Incorporated account plan
Life and health reinsurance
At a glance
RGA is a global life and health reinsurer with $4.4 trillion of life reinsurance in force, $23,698M revenues in 2025 and about 4,300 employees.
Reinsurance Group of America (RGA) is an insurance holding company whose subsidiaries provide traditional life and health reinsurance and financial solutions (asset-intensive, longevity, pension risk transfer and capital solutions) to life insurers in the U.S., Latin America, Canada, EMEA and Asia Pacific. It believes it is the largest global life and health reinsurer based on 2024 life and health reinsurance revenues, and wins business primarily directly from the world's largest life insurers rather than through brokers. FY2025 total revenues were $23,698M and net income available to shareholders $1,182M ($17.69 diluted EPS). It employs about 4,300 people and had assets of $169.5 billion at September 30, 2026. Tony Cheng has been President and CEO since January 1, 2024.
Business units
U.S. and Latin America
$12,331M segment revenues in 2025 (about 51%, computed)Traditional reinsurance of individual mortality, long-term care and group life and health, plus Financial Solutions such as annuity coinsurance, PRT group annuities, stable value and funding agreement backed notes. The Equitable Holdings block added $105M to Financial Solutions AOI over nine months of 2026. Led by Ron Herrmann, President of RGA Reinsurance Company.
Asia Pacific
$5,146M segment revenues in 2025 (about 21%, computed)Individual and group life and health, critical illness, disability and Australian superannuation cover, plus financial reinsurance and asset-intensive blocks; AOI grew to $759M in 2025, the strongest of any region. Financial Solutions invested assets rose to $40.5B in 2026. Led by Arthur Ozeki.
Europe, Middle East and Africa
$3,844M segment revenues in 2025 (about 16%, computed)Life and health, critical illness and underwritten annuities in the U.K., Continental Europe, South Africa and the Middle East, plus closed block annuity and longevity swap reinsurance. A $222M U.K. mortality assumption update hit 2025; Q3 2026 AOI recovered to $172M. Led by Cormac Galvin.
Canada
$2,035M segment revenues in 2025 (about 8%, computed)Individual life, creditor, group, critical illness and disability reinsurance, with RGA Canada a leader in facultative reinsurance, plus annuity and longevity solutions. AOI was $194M in 2025, and the five largest clients account for 58% of regional gross premiums.
Corporate and Other
$699M segment revenues in 2025 (about 3%, computed)Investment income on unallocated assets, unallocated overhead, debt interest and older funding notes; it posted an adjusted operating loss of $218M in 2025.
Strategic priorities
- Four strategic pillars
- Win-win transactions, scaling the global platform, optimizing the balance sheet (in-force management, investment returns, internal and third-party capital) and disciplined capital stewardship.
- Intermediate-term financial targets
- 8%-10% EPS growth, 13%-15% ROE and a 20%-30% payout ratio, reaffirmed in 2026.
- Strategic underwriting programs
- U.S. Strategic Underwriting Programs volumes are on track to double and accounted for almost half of Q3 2026 cases, creating exclusive reinsurance business.
- Third-party capital
- Ruby Re sidecar capital is fully deployed and RGA is evaluating options and structures for its next sidecar vehicle.
- Reducing earnings volatility
- In-force actions have cut U.S. capped cohort exposure by 25% since LDTI adoption, and RGA decided to exit medical excess from 2027.
- New segment reporting
- From Q4 2026 RGA reports four segments (Americas, EMEA, APAC, Corporate), dropping the Traditional and Financial Solutions split.
Latest results
In Q3 2026 net premiums rose to $5,352M from $4,280M and total revenues to $7,550M, with net investment income of $1,934M. Net income available to shareholders was $456M ($6.92 diluted EPS) versus $253M, and adjusted operating income before taxes $736M versus $385M, helped by favorable claims in all segments, higher variable investment income and the absence of the prior-year $149M assumption loss. Over nine months adjusted operating income reached $2,108M versus $1,291M. Trailing 12-month adjusted operating ROE was 19.1%, and excess capital was about $1.8 billion. The 10-K gives no numerical guidance.
Investments and deals
- Equitable Holdings transaction
- 75% quota share of approximately $12 billion of Equitable's in-force individual life liabilities, closed July 31, 2025, funded partly by $700M of 6.65% subordinated debentures due 2055.
- In-force transactions
- Nearly $500 million deployed into in-force deals by mid-2026 and $119 million more in Q3 2026.
- Pension risk transfer and longevity
- Four PRT transactions totaling over $800 million in Q3 2026, plus U.K. and continental European longevity deals.
- Asia Pacific asset growth
- Asia Pacific Financial Solutions invested assets grew to $40.5B from $28.7B, about $7.1 billion from recently executed transactions.
- Capital returns
- A $500M repurchase program authorized January 29, 2026 with about $325 million left at September 30, 2026; quarterly dividend of $0.98.
Challenges and risks
- Mortality and morbidity risk
- The 10-K calls mortality and morbidity the most significant risk; the 2025 assumption review cost $149M pre-tax, mainly U.K. mortality.
- Price competition for blocks
- New reinsurance opportunities are highly price competitive, with private equity firms and new entrants competing for large in-force asset-intensive blocks.
- Regulatory scrutiny
- NAIC scrutiny of captives and offshore asset-intensive reinsurance, Solvency II and rules on AI and underwriting bias.
- Ratings and interest rates
- Moody's ratings are on negative outlook, and a 100 bps rise in rates would cut the fair value of fixed maturity securities by $8,226 million.
- Client concentration
- The five largest clients generate about $3.9 billion or 21% of gross premiums and other revenues, and 58% in Canada.
What leadership says
“delivered excellent results this quarter, with strong performance across all regions”
“RGA's underwriting capabilities are expanding from a value-added service into a primary driver of reinsurance value.”
“We remain very selective and disciplined on ULSG and LTC risks”
“is really an output, not an input”
Where a supplier can help
- Underwriting technology and data
- Tied to the strategic underwriting programs priority: data, analytics and electronic underwriting tools that scale programs now driving almost half of U.S. cases.
- Integration of large blocks
- Tied to the Equitable transaction and in-force deal flow: policy administration, data migration and actuarial systems for acquired blocks.
- Regulatory and AI compliance
- Tied to the regulatory scrutiny challenge: compliance, model governance and bias-testing solutions for AI in underwriting.
- Finance reporting change
- Tied to the new segment reporting priority: finance systems and advisory support to recast history into four segments.
- Investment and risk analytics
- Tied to the ratings and interest rates challenge: portfolio, ALM and risk analytics for an invested asset base that keeps growing.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Reinsurance Group of America, Incorporated?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Annual Report on Form 10-K for fiscal year 2025
- RGA (Reinsurance Group of America) is a life and health reinsurer with $4.3 trillion of life reinsurance in force and assets of $156.6 billion as of December 31, 2025; it believes it is the largest global life and health reinsurer based on 2024 life and health reinsurance revenues. About 4,300 employees.
- FY2025: total revenues $23,698M (2024: $22,107M), net premiums $17,230M (2024: $17,843M, lower due to fewer single premium PRT deals), net investment income $5,806M; net income available to shareholders $1,182M ($17.69 diluted EPS) vs $717M; adjusted operating income before taxes $1,967M vs $1,752M.
- Four geographic segments, each split into Traditional and Financial Solutions: U.S. and Latin America (segment revenues $12,331M), Asia Pacific ($5,146M), EMEA ($3,844M), Canada ($2,035M), plus Corporate and Other.
- Landmark deal: on July 31, 2025 U.S. Financial Solutions assumed a 75% quota share of Equitable Holdings' in-force individual life liabilities (approx. $12 billion), adding $68M to pre-tax income in 2025; funded partly by $700M of 6.65% subordinated debentures due 2055.
- Growth drivers named: strong Traditional growth in Asia and Financial Solutions (longevity, asset-intensive) in the U.K.; new life business production of $733.5 billion vs $505.4 billion in 2024.
- Weak spots: annual assumption review cost $149M pre-tax, mainly U.K. mortality ($222M hit in EMEA Traditional); adverse U.S. individual life and group health claims.
- Customers are the world's largest life insurers: five largest clients about $3.9B or 21% of gross premiums and other revenues; business is obtained primarily directly rather than through brokers.
- Capital: $5.8B of debt, $240M dividends and $125M buybacks in 2025, new $500M repurchase authorization (January 29, 2026); third-party sidecar Ruby Re reinsures U.S. asset-intensive business.
- Leadership at filing: Tony Cheng (President and CEO since January 1, 2024), Axel André (CFO), Laura Cockrill (Chief Strategy Officer), Leslie Barbi (CIO, retiring April 15, 2026).
- Quarterly Report on Form 10-Q for the quarter ended September 30, 2026
- Q3 2026 (quarter to September 30, 2026): net premiums $5,352M (+$1,072M vs Q3 2025), total revenues $7,550M, net investment income $1,934M.
- Net income available to RGA shareholders $456M ($6.92 diluted EPS) vs $253M; nine months $1,248M ($18.91) vs $719M.
- Adjusted operating income before taxes $736M vs $385M; nine months $2,108M vs $1,291M, helped by the Equitable Holdings block (+$105M over nine months), higher variable investment income and favorable claims in all segments.
- The 2026 annual assumption review had no net impact on consolidated pre-tax income (2025: $149M loss, mainly U.K. mortality).
- Investment yield excluding spread business 5.26% in Q3 (4.73% a year earlier); average invested assets $49.4B over nine months.
- Asia Pacific Financial Solutions invested assets rose to $40.5B from $28.7B (about $7.1B from new transactions); U.S. Financial Solutions asset base $46.7B, with single-premium PRT deals in the quarter.
- EMEA swung to Q3 AOI of $172M from a $52M loss; U.S. and Latin America AOI $295M vs $236M.
- Life reinsurance in force $4,378.5B; assets $169.5B; $325M left on the buyback authorization; quarterly dividend $0.98.
- RGA Q3 2026 earnings call transcript
- Q3 2026 call (November 6, 2026): CEO Tony Cheng called it an excellent quarter "with strong performance across all regions"; CFO Laura Cockrill reported pre-tax adjusted operating income of $736 million, or $8.49 per share after tax, and trailing 12-month adjusted operating ROE of 19.1%.
- U.S. PRT and U.K. longevity markets picked up after a slow start; RGA completed four PRT transactions totaling over $800 million of premium.
- Ruby Re sidecar capital is now fully deployed; third-party capital "remains a core element of our capital management strategy"; no comment yet on the next vehicle.
- Asia: flow deals in Hong Kong and Japan; electronic underwriting live with one client in India; Japan helped by regulatory tailwinds.
- U.S. strategic underwriting program accounted for almost half of the quarter's cases.
- Capital: $119 million deployed into in-force deals, $139 million returned, $1.8 billion excess capital after using $400 million to retire a senior security.
- From Q4 2026 reporting moves to four segments (Americas, EMEA, APAC, Corporate), dropping the Traditional / Financial Solutions split.
- CRO Jonathan Porter retires in early 2027; Meyrick Douglas (ex-Prudential, Morgan Stanley) becomes CRO on January 1, 2027. RGA is exiting medical excess.
- RGA Q2 2026 earnings call transcript
- Q2 2026 call (August 7, 2026), Laura Cockrill's first as CFO: a "record result" with pre-tax adjusted operating income of $761 million, or $8.89 per share after tax, and trailing 12-month adjusted operating ROE of 18.4%.
- Strong across all regions: Asia Pacific (deals in Hong Kong and Japan), EMEA ahead of expectations, U.S. helped by new business and investment income; U.S. group repricing on track.
- U.S. Strategic Underwriting Programs volumes "on track to double" and are by nature reinsurance exclusives; one underwriting relationship grew into a long-term in-force transaction.
- Nearly $500 million deployed into in-force transactions year to date; $111 million returned in the quarter; dividend raised 5.4%; $2.2 billion excess capital; $400 million of debt to be repaid in September.
- In-force actions cut U.S. capped cohort exposure by 25% since LDTI adoption; excluding non-recurring items traditional premiums grew 3% year to date and total U.S. premium ex-PRT about 8%.
- Targets reaffirmed: 8%-10% EPS growth, 13%-15% ROE, 20%-30% payout ratio.
- ULSG and LTC liabilities are under 10% of the balance sheet and expected to stay there; Ruby Re expected fully deployed this year, next sidecar being evaluated.
Questions about Reinsurance Group of America, Incorporated
What does RGA do?
RGA provides life and health reinsurance and financial solutions, such as asset-intensive, longevity and pension risk transfer reinsurance, to life insurers worldwide. It had $4.4 trillion of life reinsurance in force in 2026.
What is RGA's revenue?
Total revenues were $23,698M in 2025, with net income available to shareholders of $1,182M. Q3 2026 total revenues were $7,550M.
How many employees does RGA have?
RGA employs approximately 4,300 people.
What is RGA's strategy?
RGA focuses on win-win transactions, scaling its global platform, optimizing the balance sheet with internal and third-party capital, and disciplined capital stewardship, targeting 8%-10% EPS growth and 13%-15% ROE.
Who leads RGA?
Tony Cheng is President and CEO, Laura Cockrill is CFO, and Meyrick Douglas becomes Chief Risk Officer on January 1, 2027.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)